FDA makes alarm fatigue an issue in new device approval process

03/27/2012 | Boston Globe (tiered subscription model), The

The FDA said it will provide more training on the safety issues of alarm fatigue to staff who evaluate approval applications for medical devices in hospitals. The FDA will also consider whether alarms on new devices actually provide information important to patient care.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY